Talimogene Laherparepvec (T-VEC or Imlygic)
nadofaragene firadenovec-vncg (ADSTILADRIN)
Entyvio (Vedolizumab): A Guide to Treatment for IBD
Briumvi (ublituximab-xiiy): A Targeted Therapy for Relapsing Multiple Sclerosis
Epoetin Alfa (Procrit)
Enfortumab Vedotin-ejfv (PADCEV)
Dupilumab (Dupixent)
Doxorubicin Hydrochloride Liposome
Docetaxel (Taxotere)
Denosumab (Prolia)